[Organic mixed affective disorder].
Sasaki M.
Ryoikibetsu Shokogun Shirizu. 2003;(40):180-3.
Pseudodementia.
Fisman M.
Prog Neuropsychopharmacol Biol Psychiatry. 1985;9(5-6):481-4. doi: 10.1016/0278-5846(85)90005-3.
State and trait markers to define the continuum of affective disorders.
Stoyanov D.
J Affect Disord. 2025 Mar 1;372:37-39. doi: 10.1016/j.jad.2024.11.078. Epub 2024 Nov 29.
Clotiapine for acute psychotic illnesses.
Carpenter S, Berk M.
Cochrane Database Syst Rev. 2001;(1):CD002304. doi: 10.1002/14651858.CD002304.
[Diagnostics and early recognition of bipolar disorders].
Schäfer M, Correll CU.
Nervenarzt. 2020 Mar;91(3):207-215. doi: 10.1007/s00115-020-00881-5.
[Fluvoxamine in the treatment of anxiety-depressive spectrum disorders].
Medvedev VE, Kardashian RA, Frolova VI.
Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(6):101-109. doi: 10.17116/jnevro2024124061101.
Exposure to environmental chemicals and perinatal psychopathology.
Jacobson MH, Ghassabian A, Gore AC, Trasande L.
Biochem Pharmacol. 2022 Jan;195:114835. doi: 10.1016/j.bcp.2021.114835. Epub 2021 Nov 11.
Gut-brain axis volatile organic compounds derived from breath distinguish between schizophrenia and major depressive disorder.
Henning D, Lüno M, Jiang C, Meyer-Lotz G, Hoeschen C, Frodl T.
J Psychiatry Neurosci. 2023 Apr 12;48(2):E117-E125. doi: 10.1503/jpn.220139. Print 2023 Mar-Apr.
[Confusing clinical presentations and differential diagnosis of bipolar disorder].
Gorwood P.
Encephale. 2004 Mar-Apr;30(2):182-93. doi: 10.1016/s0013-7006(04)95430-9.
The Addenbrooke's cognitive examination (ACE) in the differential diagnosis of early dementias versus affective disorder.
Dudas RB, Berrios GE, Hodges JR.
Am J Geriatr Psychiatry. 2005 Mar;13(3):218-26. doi: 10.1176/appi.ajgp.13.3.218.
